Acrux Limited


 Acrux (ASX: ACR) is a pharmaceutical company dedicated to developing and commercialising topical pharmaceuticals. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and commercialised through licensees a number of topically applied pharmaceutical products in the US and Europe. Acrux is developing of a range of generic products for the US market by leveraging its on-site laboratories, GMP manufacturing suite, clinical and commercial experience to bring affordable products to market. Acrux encourages collaboration and is well positioned to discuss partnering and product development.  

View in Other Languages


Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 11948

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article

Australian Market Report of June 22: Break the Losing Streak

🕔6/22/2009 1:00:22 PM 16523

Last Friday, the Australian shares ended higher for the first time in a week. The benchmark S&P/ASX200 index gained 7.5 points, or 0.19 per cent, to 3,899.6 points, and the broader All Ordinaries index advanced 7 points, or 0.18 per cent, at 3894.4 points.

Read Full Article

Acrux Limited (ASX:ACR) and KV Pharmaceutical (NYSE:KV-A) Launch EVAMIST Skin Spray Drug Delivery Technology in US

🕔4/16/2008 11:20:17 AM 8356

Acrux (ASX: ACR)(PNK:ARUXF) today announced that Evamist(tm), the first product utilising its unique skin spray drug delivery technology, has been launched by US licensee KV Pharmaceutical Company (NYSE: KVa/KVb) into one of the largest therapeutic categories in women's healthcare.

Read Full Article

ACRUX LIMITED ASX: ACR - Market Briefing - Mr Igor Gonda, MD & CEO

🕔4/27/2006 2:00:00 PM 6502

ACRUX LIMITED (ASX: ACR) - Market Briefing - Mr Igor Gonda, MD & CEO; Boardroomradio is pleased to announce that ACRUX LIMITED (ASX: ACR) has published an audio file. The following presentation "ACR -

Read Full Article


  • This Page Viewed: (Last 7 Days: 13) (Last 30 Days: 56) (Since Published: 9126) 

Company Data

  • 103-113 Stanley Street
    West Melbourne
  • Telephone
  • +61 3 83790100 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Listed
  • 2004/09/29 
  • Homepage

More News Results

  • 2024/02/23: Investor Webinar Details - Financial Results 1H FY24*
*refer to company website

Social Media